AS202917
Cigna HLA Technology Services Company Ltd
AS202917 is Cigna HLA Technology Services Company Ltd. It announces 8,192 IPv4 addresses in 19 prefixes, and 0 IPv6 prefixes.
Hong Kong· RIPE· allocated 2016-05-04· business
8,192
IPv4 addresses announced
19
IPv4 prefixes
0
IPv6 prefixes
0.00%
of its routes RPKI-valid
8,192
of its IPv4 geolocated
2
countries
Where its space is
The IPv4 it announces that IP Geolocation places, by country. A /24 counts for the AS announcing most of it.
- United States7,936 · 96.88%
- United Kingdom256 · 3.13%
Registry record
Its ASN Whois record, as the registry publishes it.
- handle
- CIGNA-UK
- name
- Cigna HLA Technology Services Company Ltd
- org
- ORG-CHTS1-RIPE
- org name
- Cigna HLA Technology Services Company Ltd
- org address
- Room 3401, 34th Floor, The Lee Gardens, 33 Hysan Avenue, Causeway Bay, Hong Kong
- org country
- HK
- country
- HK
- source
- ripe
- status
- ASSIGNED
- created
- 2016-05-04
- updated
- 2020-11-16
- maintainer
- RIPE-NCC-END-MNT|CW-EUROPE-GSOC
- abuse name
- Abuse-C Role
- abuse email
- ipabuse@vodafone.co.uk
- abuse kind
- role
What the databases see
Addresses each address-keyed database holds in the IPv4 it announces, as a share of that space, with its largest providers. Counts overlap.
- None here
- None here
- None here
- None here
- None here
- None here
- None here
- None here
- None here
- None here
- 0.04%
- None here
- None here
IPv4 prefixes
Every IPv4 prefix BGP Route saw it announce. A prefix another AS also announces says so.
| PREFIX | COUNTRY | RPKI | PEERS | FIRST SEEN |
|---|---|---|---|---|
| 170.48.64.0/20 | United States | not found | 17 | 2026-10-02 |
| 170.48.64.0/24 | United States | not found | 17 | 2026-10-02 |
| 170.48.65.0/24 | United States | not found | 17 | 2026-10-02 |
| 170.48.68.0/23 | United States | not found | 17 | 2026-10-02 |
| 170.48.70.0/23 | United States | not found | 17 | 2026-10-02 |
| 170.48.72.0/23 | United States | not found | 17 | 2026-10-02 |
| 170.48.74.0/24 | United States | not found | 17 | 2026-10-02 |
| 170.48.128.0/20 | United States | not found | 17 | 2026-10-02 |
| 170.48.128.0/23 | United States | not found | 17 | 2026-10-02 |
| 170.48.128.0/24 | United States | not found | 17 | 2026-10-02 |
| 170.48.129.0/24 | United States | not found | 17 | 2026-10-02 |
| 170.48.130.0/23 | United States | not found | 17 | 2026-10-02 |
| 170.48.130.0/24 | United States | not found | 17 | 2026-10-02 |
| 170.48.131.0/24 | United States | not found | 17 | 2026-10-02 |
| 170.48.132.0/23 | United States | not found | 17 | 2026-10-02 |
| 170.48.134.0/23 | United States | not found | 17 | 2026-10-02 |
| 170.48.136.0/23 | United States | not found | 17 | 2026-10-02 |
| 170.48.138.0/23 | United States | not found | 17 | 2026-10-02 |
| 193.240.190.0/24 | United Kingdom | not found | 17 | 2026-10-02 |
00 · Evaluate
Test the real build first.
An evaluation license puts a full current build in your hands — every row, every column, no sampling — so you can measure it against your own traffic before anyone talks about terms.
01 · License
Then license what you use.
Standard, for detection and decisions inside your own product and operations.
Redistribution, when the data ships onward inside what you sell — priced by scope, not by seat.
Annual terms, a named contact, and flexible payment terms — monthly, quarterly or yearly.